KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy

  • Authors:
    • L. S. Yamane
    • C. Scapulatempo-Neto
    • L. Alvarenga
    • C. Z. Oliveira
    • G. N. Berardinelli
    • E. Almodova
    • T. R. Cunha
    • G. Fava
    • W. Colaiacovo
    • A. Melani
    • J. H. Fregnani
    • R. M. Reis
    • D. P. Guimarães
  • View Affiliations

  • Published online on: July 18, 2014     https://doi.org/10.3892/or.2014.3338
  • Pages: 1419-1426
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal cancer (CRC) is one of the most frequent cancers worldwide. Adenoma is the main precursor lesion and, recently, the serrated polyps were described as a group of colorectal lesions with malignant potential. The morphologic and biologic characterizations of serrated polyps remain limited. The aim of the present study was to determine the frequency of KRAS and BRAF mutations and microsatellite instability (MSI) in CRC precursor lesions, to evaluate the association between molecular, pathologic and morphologic alterations in precursor lesions and to compare with the alterations detected in CRC. A series of 342 precursor lesions were removed from 155 patients during colonoscopy. After morphologic classification, molecular analysis was performed in 103 precursor lesions, and their genetic profile compared with 47 sporadic CRCs. Adenomas were the main precursor lesions (70.2%). Among the serrated polyps, the main precursor lesion was hyperplastic polyps (HPs) (82.4%), followed by sessile serrated adenomas (12.7%) and traditional serrated adenomas (2.0%). KRAS mutations were detected in 13.6% of the precursor lesions, namely in adenomas and in HPs, but in no serrated adenoma. BRAF mutations were found in 9 (8.7%) precursor lesions, mainly associated with serrated polyps and absent in adenomas (P<0.001). High MSI (MSI-H) was absent in precursor lesions. In the 47 CCR cases, 46.8% exhibited KRAS mutation, 6.5% BRAF mutations and 10.6% MSI-H. This study confirms the role of KRAS and BRAF mutations in CRC carcinogenesis, a crucial step in implementing CRC screening strategies.
View Figures
View References

Related Articles

Journal Cover

October 2014
Volume 32 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yamane LS, Scapulatempo-Neto C, Alvarenga L, Oliveira CZ, Berardinelli GN, Almodova E, Cunha TR, Fava G, Colaiacovo W, Melani A, Melani A, et al: KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy. Oncol Rep 32: 1419-1426, 2014.
APA
Yamane, L.S., Scapulatempo-Neto, C., Alvarenga, L., Oliveira, C.Z., Berardinelli, G.N., Almodova, E. ... Guimarães, D.P. (2014). KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy. Oncology Reports, 32, 1419-1426. https://doi.org/10.3892/or.2014.3338
MLA
Yamane, L. S., Scapulatempo-Neto, C., Alvarenga, L., Oliveira, C. Z., Berardinelli, G. N., Almodova, E., Cunha, T. R., Fava, G., Colaiacovo, W., Melani, A., Fregnani, J. H., Reis, R. M., Guimarães, D. P."KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy". Oncology Reports 32.4 (2014): 1419-1426.
Chicago
Yamane, L. S., Scapulatempo-Neto, C., Alvarenga, L., Oliveira, C. Z., Berardinelli, G. N., Almodova, E., Cunha, T. R., Fava, G., Colaiacovo, W., Melani, A., Fregnani, J. H., Reis, R. M., Guimarães, D. P."KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy". Oncology Reports 32, no. 4 (2014): 1419-1426. https://doi.org/10.3892/or.2014.3338